Trends of presentation and clinical outcome of treated renal angiomyolipoma

Kyo Chul Koo, Won Tae Kim, Won Sik Ham, Jin Sun Lee, Hee Jeong Ju, Young Deuk Choi

Research output: Contribution to journalReview article

32 Citations (Scopus)

Abstract

Purpose: The purpose of this study is to set guidelines for the management of renal angiomyolipoma (AML), clinical prognosis according to tumor size, in association with tuberous sclerosis complex (TSC), multiplicity, radiographic finding, and treatment modality. Materials and Methods: Between March 1998 and October 2008, 129 out of 254 patients with AML who underwent surgical intervention or angioembolization were enrolled. Diagnosis of AML was determined by the presence of a low attenuated component on CT imaging or by pathological confirmation. Indications of treatment were intractable pain, hematuria, suspicion of malignancy, large tumor size, spontaneous rupture, and radiographically equivocal tumors in which a differential diagnosis was needed to rule out malignancy. Parameters including age, sex, tumor size, multiplicity, radiographic characteristics, association with TSC, and treatment modality were reviewed. Results: Age at presentation was 50.6 years and mean tumor size was 3.5 cm. Presentation symptoms were flank pain, hematuria, spontaneous rupture, and fatigue. 97 (75.2%) patients were incidentally discovered. 100 (77.5%) were females. 68 (52.7%) underwent nephron-sparing surgery (NSS), 35 (27.1%) radical nephrectomy, and 26 (20.2%) angioembolization. TSC was accompanied in 12 (9.3%) patients. No patient developed renal function impairment during the mean follow-up period of 64.8 months. Patients with TSC presented at a younger age, along with larger, bilateral, and multiple lesions. Conclusion: Significant differences in clinical manifestations and treatment outcomes were noted in respect to tumor characteristics, association with TSC, and treatment modality. Considering the benign nature of AML, these parameters ought to be considered when deciding upon active surveillance or prophylactic intervention.

Original languageEnglish
Pages (from-to)728-734
Number of pages7
JournalYonsei medical journal
Volume51
Issue number5
DOIs
Publication statusPublished - 2010 Sep

Fingerprint

Angiomyolipoma
Tuberous Sclerosis
Kidney
Neoplasms
Spontaneous Rupture
Hematuria
Flank Pain
Intractable Pain
Nephrons
Therapeutics
Nephrectomy
Fatigue
Differential Diagnosis
Guidelines

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Koo, Kyo Chul ; Kim, Won Tae ; Ham, Won Sik ; Lee, Jin Sun ; Ju, Hee Jeong ; Choi, Young Deuk. / Trends of presentation and clinical outcome of treated renal angiomyolipoma. In: Yonsei medical journal. 2010 ; Vol. 51, No. 5. pp. 728-734.
@article{8f0b9878048749ceb8f5954396bb187a,
title = "Trends of presentation and clinical outcome of treated renal angiomyolipoma",
abstract = "Purpose: The purpose of this study is to set guidelines for the management of renal angiomyolipoma (AML), clinical prognosis according to tumor size, in association with tuberous sclerosis complex (TSC), multiplicity, radiographic finding, and treatment modality. Materials and Methods: Between March 1998 and October 2008, 129 out of 254 patients with AML who underwent surgical intervention or angioembolization were enrolled. Diagnosis of AML was determined by the presence of a low attenuated component on CT imaging or by pathological confirmation. Indications of treatment were intractable pain, hematuria, suspicion of malignancy, large tumor size, spontaneous rupture, and radiographically equivocal tumors in which a differential diagnosis was needed to rule out malignancy. Parameters including age, sex, tumor size, multiplicity, radiographic characteristics, association with TSC, and treatment modality were reviewed. Results: Age at presentation was 50.6 years and mean tumor size was 3.5 cm. Presentation symptoms were flank pain, hematuria, spontaneous rupture, and fatigue. 97 (75.2{\%}) patients were incidentally discovered. 100 (77.5{\%}) were females. 68 (52.7{\%}) underwent nephron-sparing surgery (NSS), 35 (27.1{\%}) radical nephrectomy, and 26 (20.2{\%}) angioembolization. TSC was accompanied in 12 (9.3{\%}) patients. No patient developed renal function impairment during the mean follow-up period of 64.8 months. Patients with TSC presented at a younger age, along with larger, bilateral, and multiple lesions. Conclusion: Significant differences in clinical manifestations and treatment outcomes were noted in respect to tumor characteristics, association with TSC, and treatment modality. Considering the benign nature of AML, these parameters ought to be considered when deciding upon active surveillance or prophylactic intervention.",
author = "Koo, {Kyo Chul} and Kim, {Won Tae} and Ham, {Won Sik} and Lee, {Jin Sun} and Ju, {Hee Jeong} and Choi, {Young Deuk}",
year = "2010",
month = "9",
doi = "10.3349/ymj.2010.51.5.728",
language = "English",
volume = "51",
pages = "728--734",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "5",

}

Trends of presentation and clinical outcome of treated renal angiomyolipoma. / Koo, Kyo Chul; Kim, Won Tae; Ham, Won Sik; Lee, Jin Sun; Ju, Hee Jeong; Choi, Young Deuk.

In: Yonsei medical journal, Vol. 51, No. 5, 09.2010, p. 728-734.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Trends of presentation and clinical outcome of treated renal angiomyolipoma

AU - Koo, Kyo Chul

AU - Kim, Won Tae

AU - Ham, Won Sik

AU - Lee, Jin Sun

AU - Ju, Hee Jeong

AU - Choi, Young Deuk

PY - 2010/9

Y1 - 2010/9

N2 - Purpose: The purpose of this study is to set guidelines for the management of renal angiomyolipoma (AML), clinical prognosis according to tumor size, in association with tuberous sclerosis complex (TSC), multiplicity, radiographic finding, and treatment modality. Materials and Methods: Between March 1998 and October 2008, 129 out of 254 patients with AML who underwent surgical intervention or angioembolization were enrolled. Diagnosis of AML was determined by the presence of a low attenuated component on CT imaging or by pathological confirmation. Indications of treatment were intractable pain, hematuria, suspicion of malignancy, large tumor size, spontaneous rupture, and radiographically equivocal tumors in which a differential diagnosis was needed to rule out malignancy. Parameters including age, sex, tumor size, multiplicity, radiographic characteristics, association with TSC, and treatment modality were reviewed. Results: Age at presentation was 50.6 years and mean tumor size was 3.5 cm. Presentation symptoms were flank pain, hematuria, spontaneous rupture, and fatigue. 97 (75.2%) patients were incidentally discovered. 100 (77.5%) were females. 68 (52.7%) underwent nephron-sparing surgery (NSS), 35 (27.1%) radical nephrectomy, and 26 (20.2%) angioembolization. TSC was accompanied in 12 (9.3%) patients. No patient developed renal function impairment during the mean follow-up period of 64.8 months. Patients with TSC presented at a younger age, along with larger, bilateral, and multiple lesions. Conclusion: Significant differences in clinical manifestations and treatment outcomes were noted in respect to tumor characteristics, association with TSC, and treatment modality. Considering the benign nature of AML, these parameters ought to be considered when deciding upon active surveillance or prophylactic intervention.

AB - Purpose: The purpose of this study is to set guidelines for the management of renal angiomyolipoma (AML), clinical prognosis according to tumor size, in association with tuberous sclerosis complex (TSC), multiplicity, radiographic finding, and treatment modality. Materials and Methods: Between March 1998 and October 2008, 129 out of 254 patients with AML who underwent surgical intervention or angioembolization were enrolled. Diagnosis of AML was determined by the presence of a low attenuated component on CT imaging or by pathological confirmation. Indications of treatment were intractable pain, hematuria, suspicion of malignancy, large tumor size, spontaneous rupture, and radiographically equivocal tumors in which a differential diagnosis was needed to rule out malignancy. Parameters including age, sex, tumor size, multiplicity, radiographic characteristics, association with TSC, and treatment modality were reviewed. Results: Age at presentation was 50.6 years and mean tumor size was 3.5 cm. Presentation symptoms were flank pain, hematuria, spontaneous rupture, and fatigue. 97 (75.2%) patients were incidentally discovered. 100 (77.5%) were females. 68 (52.7%) underwent nephron-sparing surgery (NSS), 35 (27.1%) radical nephrectomy, and 26 (20.2%) angioembolization. TSC was accompanied in 12 (9.3%) patients. No patient developed renal function impairment during the mean follow-up period of 64.8 months. Patients with TSC presented at a younger age, along with larger, bilateral, and multiple lesions. Conclusion: Significant differences in clinical manifestations and treatment outcomes were noted in respect to tumor characteristics, association with TSC, and treatment modality. Considering the benign nature of AML, these parameters ought to be considered when deciding upon active surveillance or prophylactic intervention.

UR - http://www.scopus.com/inward/record.url?scp=77957958530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957958530&partnerID=8YFLogxK

U2 - 10.3349/ymj.2010.51.5.728

DO - 10.3349/ymj.2010.51.5.728

M3 - Review article

C2 - 20635448

AN - SCOPUS:77957958530

VL - 51

SP - 728

EP - 734

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 5

ER -